Latest stories
Featured
Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®...
Press Release, Business Development 12 February 2024
- Hikma completes Xellia acquisition Press Release, Corporate 10 September 2024 Hikma completes Xellia acquisition
- Hikma launches Clindamycin in 5% Dextrose Injection in the US Press Release, Product 03 September 2024 Hikma launches Clindamycin in 5% Dextrose Injection in the US
- Bringing Better Health Within Reach: Improving access to medicine as the partner of choice in MENA Insight, Corporate 28 August 2024 Bringing Better Health Within Reach: Improving access to medicine as the partner of choice in MENA
- Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention Day Press Release, Product 20 August 2024 Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention Day
Related content